Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
107.81%
-
Total 13F principal
-
$904,737,980
-
Principal change
-
-$110,517,870
-
Total reported market value
-
$978,480,958
-
Number of holders
-
64
-
Value change
-
-$105,420,245
-
Number of buys
-
28
-
Number of sells
-
35
Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 as of Q2 2024
As of 30 Jun 2024,
ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 was held by
64 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$904,737,980
in principal (par value) of the bond.
The largest 10 bondholders included
Voya Investment Management LLC, Aequim Alternative Investments LP, LAZARD ASSET MANAGEMENT LLC, Davidson Kempner Capital Management LP, Linden Advisors LP, Calamos Advisors LLC, Invesco Ltd., D. E. Shaw & Co., Inc., ADVENT CAPITAL MANAGEMENT /DE/, and CITADEL ADVISORS LLC.
This page lists
65
institutional bondholders reporting positions
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.